{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:30:23Z","timestamp":1790501423341,"version":"4.1.0"},"reference-count":74,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,3,11]],"date-time":"2004-03-11T00:00:00Z","timestamp":1078963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2004,5]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> von Willebrand disease (VWD) is the commonest inherited bleeding disorder. The aim of therapy for VWD is to correct the two defects of haemostasis in this disorder, impaired primary haemostasis because of defective platelet adhesion and aggregation and impaired coagulation as a result of low levels of factor VIII. The objective of this guideline is to inform individuals making choices about the treatment and management of VWD including the use of therapeutic products. This is the second edition of this UK Haemophilia Centre Doctors' Organization (UKHCDO) guideline and supersedes the previous edition which was published in 1994.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2004.00886.x","type":"journal-article","created":{"date-parts":[[2004,4,14]],"date-time":"2004-04-14T13:17:38Z","timestamp":1081948658000},"page":"218-231","source":"Crossref","is-referenced-by-count":109,"title":["Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization"],"prefix":"10.1111","volume":"10","author":[{"given":"K. J.","family":"Pasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. W.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. M.","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Cumming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. C.","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. R. M.","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. G. H.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Laffan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. R.","family":"Peake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,3,11]]},"reference":[{"key":"e_1_2_56_2_2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler JE.","year":"1994","journal-title":"Thromb Haemost"},{"issue":"2","key":"e_1_2_56_3_2","first-page":"4","article-title":"Guidelines for the diagnosis and management of von Willebrand disease","volume":"3","author":"UK Haemophilia Centre Doctors\u2019 Organisation von Willebrand Disease Working Party","year":"1997","journal-title":"Haemophilia"},{"key":"e_1_2_56_4_2","first-page":"276","article-title":"Desmopressin: a nontransfusional treatment of hemophilia and von Willebrand disease","volume":"22","author":"Mannucci PM","year":"1992","journal-title":"Haemostasis"},{"key":"e_1_2_56_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05127.x"},{"key":"e_1_2_56_6_2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0038-1657745","article-title":"Comparison between subcutaneous and intravenous DDAVP in mild and moderate hemophilia A","volume":"54","author":"De Sio L","year":"1985","journal-title":"Thromb Haemost"},{"key":"e_1_2_56_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1646050"},{"key":"e_1_2_56_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01738476"},{"key":"e_1_2_56_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00367.x"},{"key":"e_1_2_56_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198310063091402"},{"key":"e_1_2_56_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1990.tb00412.x"},{"key":"e_1_2_56_12_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1055\/s-0038-1647265","article-title":"1\u2010Desamino\u20108\u2010D\u2010arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia","volume":"64","author":"Casonato A","year":"1990","journal-title":"Thromb Haemost"},{"key":"e_1_2_56_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199412000-00013"},{"key":"e_1_2_56_14_2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0037-1614447","article-title":"Post\u2010DDAVP thrombocytopenia in type 2B von Willebrand disease is not associated with platelet consumption: failure to demonstrate glycocalicin increase or platelet activation","volume":"81","author":"Casonato A","year":"1999","journal-title":"Thromb Haemost"},{"key":"e_1_2_56_15_2","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1182\/blood.V74.5.1859.1859","article-title":"DDAVP for type IIB von Willebrand disease","volume":"74","author":"Fowler WE","year":"1989","journal-title":"Blood"},{"key":"e_1_2_56_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199602)51:2<158::AID-AJH11>3.0.CO;2-E"},{"key":"e_1_2_56_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.1996.tb00018.x"},{"key":"e_1_2_56_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198801143180215"},{"key":"e_1_2_56_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92881-X"},{"key":"e_1_2_56_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92623-P"},{"key":"e_1_2_56_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)92560-0"},{"key":"e_1_2_56_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199807000-00025"},{"key":"e_1_2_56_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830310310"},{"key":"e_1_2_56_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.01814.x"},{"key":"e_1_2_56_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188524"},{"key":"e_1_2_56_26_2","unstructured":"British National Formulary.William Clowes Suffolk 2002;44:714."},{"key":"e_1_2_56_27_2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1649475","article-title":"Treatment with tranexamic acid during pregnancy, and the risk of thromboembolic complications","volume":"70","author":"Lindoff C","year":"1993","journal-title":"Thromb Haemost"},{"key":"e_1_2_56_28_2","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1055\/s-0038-1657590","article-title":"New treatments of von Willebrand disease: plasma derived von Willebrand factor concentrates","volume":"78","author":"Menache D","year":"1997","journal-title":"Thromb Haemost"},{"key":"e_1_2_56_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830250106"},{"key":"e_1_2_56_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.00234.x"},{"key":"e_1_2_56_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02654.x"},{"key":"e_1_2_56_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.0040s3033.x"},{"key":"e_1_2_56_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.12.3130.bloodjournal79123130"},{"key":"e_1_2_56_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.0040s3025.x"},{"key":"e_1_2_56_35_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613227"},{"key":"e_1_2_56_36_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613225"},{"key":"e_1_2_56_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.0040s3011.x"},{"key":"e_1_2_56_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1989.tb02031.x"},{"key":"e_1_2_56_39_2","first-page":"298","article-title":"Experience with Haemate\u2010P in von Willebrand's disease in adults","volume":"24","author":"Scharrer I","year":"1994","journal-title":"Haemostasis"},{"key":"e_1_2_56_40_2","first-page":"304","article-title":"Haemate\u2010P in children with von Willebrand's disease","volume":"24","author":"Kreuz W","year":"1994","journal-title":"Haemostasis"},{"key":"e_1_2_56_41_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1055\/s-0037-1614448","article-title":"Safety and efficacy of continuous infusion of a combined factor VIII\u2010von Willebrand factor (vWF) concentrate (Haemate\u2010PTM) in patients with von Willebrand disease","volume":"81","author":"Lubetsky A","year":"1999","journal-title":"Thromb Haemost"},{"key":"e_1_2_56_42_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.2.450"},{"key":"e_1_2_56_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2002.00688.x"},{"key":"e_1_2_56_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1987.tb04892.x"},{"key":"e_1_2_56_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1989.tb01244.x"},{"key":"e_1_2_56_46_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.0040s3048.x"},{"key":"e_1_2_56_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199701000-00002"},{"key":"e_1_2_56_48_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.9.1901.1901"},{"key":"e_1_2_56_49_2","first-page":"427","article-title":"Haemostasis in oral surgery\u2013the possible pathogenetic implications of oral fibrinolysis on bleeding. Experimental and clinical studies of the haemostatic balance in the oral cavity, with particular reference to patients with acquired and congenital defects of the coagulation system","volume":"38","author":"Sindet\u2010Pedersen S.","year":"1991","journal-title":"Dan Med Bull"},{"key":"e_1_2_56_50_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.00285.x"},{"key":"e_1_2_56_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199612)53:4<234::AID-AJH4>3.0.CO;2-Z"},{"key":"e_1_2_56_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)08248-2"},{"key":"e_1_2_56_53_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7138.1122"},{"key":"e_1_2_56_54_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.313.7057.579"},{"key":"e_1_2_56_55_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649813"},{"key":"e_1_2_56_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1995.tb11293.x"},{"key":"e_1_2_56_57_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.00147.x"},{"key":"e_1_2_56_58_2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1055\/s-0038-1650645","article-title":"Prospective multicenter study on subcutaneous concentrated desmopressin for home treatment of patients with von Willebrand disease and mild or moderate hemophilia A","volume":"76","author":"Rodeghiero F","year":"1996","journal-title":"Thromb Haemost"},{"issue":"1","key":"e_1_2_56_59_2","first-page":"106","article-title":"Efficacy of Stimate (desmopressin acetate) nasal spray, 1.5\u2003mg\u2003ml\u22121, for the treatment of menorrhagia in women with inherited bleeding disorders","volume":"90","author":"Kobrinsky N","year":"1997","journal-title":"Blood"},{"key":"e_1_2_56_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(95)00062-V"},{"key":"e_1_2_56_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1987.00349.x"},{"key":"e_1_2_56_62_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0306-3356(21)00186-2","article-title":"Haematological disorders","volume":"9","author":"Hill FG.","year":"1982","journal-title":"Clin Obstet Gynaecol"},{"key":"e_1_2_56_63_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649623"},{"key":"e_1_2_56_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)90729-7"},{"key":"e_1_2_56_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830460325"},{"key":"e_1_2_56_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08542-2"},{"key":"e_1_2_56_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(01)80087-6"},{"key":"e_1_2_56_68_2","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1182\/blood.V74.6.1972.1972","article-title":"DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor","volume":"74","author":"Cattaneo M","year":"1989","journal-title":"Blood"},{"key":"e_1_2_56_69_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649942"},{"key":"e_1_2_56_70_2","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20\u2003years","volume":"90","author":"Mannucci PM.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_56_71_2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood.V67.2.465.465","article-title":"DDAVP in type IIa von Willebrand's disease","volume":"67","author":"Gralnick HR","year":"1986","journal-title":"Blood"},{"issue":"1","key":"e_1_2_56_72_2","first-page":"150","article-title":"Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor","volume":"26","author":"Ciavarella N","year":"1996","journal-title":"Haemostasis"},{"key":"e_1_2_56_73_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.0050s2028.x"},{"key":"e_1_2_56_74_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0037-1613993","article-title":"Willebrand Syndrome: from pathophysiology to management","volume":"4","author":"Veyradier A","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_56_75_2","volume-title":"Acute Pain Management: Operative or Medical Procedures and Trauma","author":"AHCPR","year":"1992"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2004.00886.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2004.00886.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T05:48:04Z","timestamp":1697176084000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2004.00886.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,11]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["10.1111\/j.1365-2516.2004.00886.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2004.00886.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,11]]}}}